Genetic manipulations utilizing albumin and alpha-fetoprotein promoter/enhancers affect both hepatocytes and oval cells.
Matthews
Vance B
VB
Rose-John
Stefan
S
Yeoh
George C T
GC
D000418:Albumins / Q000235:genetics*; D000818:Animals; D015703:Antigens, CD / Q000502:physiology*; D050822:Cytokine Receptor gp130; D004742:Enhancer Elements, Genetic / Q000502:physiology*; D022781:Hepatocytes / Q000378:metabolism*; D015850:Interleukin-6 / Q000502:physiology*; D008099:Liver / Q000166:cytology*; D008562:Membrane Glycoproteins / Q000502:physiology*; D051379:Mice; D011401:Promoter Regions, Genetic / Q000502:physiology*; D000509:alpha-Fetoproteins / Q000235:genetics*
D000418:Albumins; D015703:Antigens, CD; C494200:Il6st protein, mouse; D015850:Interleukin-6; D008562:Membrane Glycoproteins; D000509:alpha-Fetoproteins; D050822:Cytokine Receptor gp130